The U.S. new cases 7-day rolling average are 13.9 % LOWER than the 7-day rolling average one week ago and U.S. deaths due to coronavirus are now 1.0 %
LOWER than the rolling average one week ago. Today s posts include:
U.S. Coronavirus New Cases are 47,784
U.S. Coronavirus deaths are at 815
U.S. Coronavirus immunizations have been administered to 75.3 doses per 100 people.
The 7-day rolling average rate of growth of the pandemic shows new cases improved and deaths improved
Immediate global ivermectin use will end COVID-19 pandemic
Pfizer-BioNTech mRNA vaccine reduces both symptomatic and asymptomatic COVID-19 infection in case study
More on non-steroidal anti-inflammatory drugs (NSAIDs) use with COVID
Immediate global ivermectin use can end pandemic: Scientists
Sat, May 08 2021 12:29:58 PM
Washington, May 8 (IANS): A peer-reviewed research has claimed that global ivermectin use can end Covid-19 pandemic, as the medicine significantly reduces the risk of contracting the deadly respiratory disease when used regularly.
The common antiparasitic ivermectin is being touted as a miracle cure for Covid-19 by doctors and campaigners the world over.
Peer reviewed by medical experts that included three US government senior scientists and published in the American Journal of Therapeutics, the research is the most comprehensive review of the available data taken from clinical, in vitro, animal, and real-world studies.
Washington: A peer-reviewed research has claimed that global ivermectin use can end COVID-19 pandemic, as the medicine significantly reduces the risk of contracting the deadly respiratory disease when used regularly.
The common antiparasitic ivermectin is being touted as a miracle cure for COVID-19 by doctors and campaigners the world over.
Peer reviewed by medical experts that included three US government senior scientists and published in the American Journal of Therapeutics, the research is the most comprehensive review of the available data taken from clinical, in vitro, animal, and real-world studies.
Led by the Front Line COVID-19 Critical Care Alliance (FLCCC), a group of medical and scientific experts reviewed published peer-reviewed studies, manuscripts, expert meta-analyses, and epidemiological analyses of regions with ivermectin distribution efforts all showing that ivermectin is an effective prophylaxis and treatment for COVID-19.
E-Mail
WASHINGTON, D.C. - Peer reviewed by medical experts that included three U.S. government senior scientists and published in the
American Journal of Therapeutics, the research is the most comprehensive review of the available data taken from clinical, in vitro, animal, and real-world studies. Led by the Front Line COVID-19 Critical Care Alliance (FLCCC), a group of medical and scientific experts reviewed published peer-reviewed studies, manuscripts, expert meta-analyses, and epidemiological analyses of regions with ivermectin distribution efforts all showing that ivermectin is an effective prophylaxis and treatment for COVID-19. We did the work that the medical authorities failed to do, we conducted the most comprehensive review of the available data on ivermectin, said Pierre Kory, M.P.A., MD, president and chief medical officer of the FLCCC. We applied the gold standard to qualify the data reviewed before concluding that ivermectin can end this pandemic.
National
April 29, 2021
SUKKUR: A discussion was held for medical professionals regarding Covid-19 treatment through Ivermectin in the early stages and IV Methylprednisolone.
The discussion was held on platform of The Impact, a non-profit organization, to facilitate and help capacity building of Pakistani healthcare professionals. Wednesday’s discussion revolved around the treatment of Covid-19 to assist the front line doctors engaged in battling the third wave of the contagion.
The keynote speaker was Professor Paul E Marik, Professor of Medicine and Chief of the Pulmonary and Critical Care Medicine Division at Eastern Virginia Medical School in Norfolk, Virginia. Marik advocated using Ivermectin in the early stages, and IV Methylprednisolone in the later “pulmonary phase” of the disease. He went on to say that these medicines were efficacious, safe, inexpensive and widely available. If used in the early stages of the disease, the drugs have proved to cause statistically